跳至主要内容
临床试验/TCTR20190128002
TCTR20190128002Enrolling By Invitation3 期

Efficacy of N-acetylcysteine for sputum smearconversion in pulmonary tuberculosis; multicenteropen- label pragmatic randomized controlled trial

Khon Kaen Hospital0 个研究点目标入组 220 人开始时间: 2019年1月28日最近更新:
适应症

试验速览

阶段
3 期
状态
Enrolling By Invitation
入组人数
220

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 0 Years(—)
性别
All

入选标准

  • The patients 18 years of age or older who newly diagnosed
  • PTB and agreement to participate in the study will eligible
  • for enrollment.

排除标准

  • We will exclude the patients who are pregnant or breastfeeding, known hypersensitivity to NAC, HIV positive, history of massive hemoptysis (NAC may exacerbate severity of hemoptysis), estimating glomerular filtration rate less than 30 mL/min/1.73 m 2 , moribund state, history of porphyria, pre-existing liver disease, known rifampicin and/or multidrug resistance tuberculosis and earlier anti-tuberculosis treatment.

研究者

相似试验

Efficacy of N-acetylcysteine for sputum smear... | 临床试验